Indonesia’s State-Owned Kimia Farma Gears Up To Produce Antiretrovirals Under Compulsory License
This article was originally published in PharmAsia News
Executive Summary
Nearly eight months after Indonesia issued a compulsory license to make seven second-line antiretroviral drugs, state-owned PT Kimia Farma does not have a timetable for the sale of the products, though a health ministry official says production trials are underway.